◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Cipher Pharmaceuticals Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 12.8M 13.4M 12.0M 11.8M 10.4M --
Operating Revenue 12.8M 13.4M 12.0M 11.8M 10.4M --
Cost Of Revenue 2.3M 2.5M 2.9M 5.1M 2.0M --
Gross Profit 10.5M 10.9M 9.1M 6.7M 8.4M --
Selling General And Administration 3.7M 4.1M 4.8M 4.8M 4.6M --
General And Administrative Expense 3.1M 4.1M 4.2M 4.1M 3.9M --
Research And Development 0.00 0.00 21,000 0.00 0.00 --
Depreciation And Amortization In Income Statement 1.8M 1.8M 1.8M 1.5M 1.9M --
Operating Expense 5.5M 5.9M 6.7M 6.4M 6.5M --
Operating Income 5.0M 5.0M 2.5M 334,000 1.9M --
EBIT 5.0M 5.0M 2.5M 334,000 1.9M --
Interest Income -- -- -- -- -- 611,000
Interest Income Non Operating -- -- -- -- -- 611,000
Net Interest Income -241,000 -345,000 -470,000 -544,000 -292,000 --
Other Income Expense -475,000 1.8M -117,000 -2.6M -1.3M --
Special Income Charges 130,000 0.00 -128,000 -854,000 -1.6M --
Restructuring And Mergern Acquisition 0.00 0.00 128,000 854,000 1.6M --
Gain On Sale Of Security -605,000 1.8M 11,000 -1.8M 325,000 --
Pretax Income 4.3M 6.4M 1.9M -2.9M 326,000 --
Tax Provision -1.2M 512,000 -737,000 -6.2M 43,000 --
Tax Effect Of Unusual Items -71,250 140,610 -17,550 -396,600 -165,141 --
Net Income From Continuing And Discontinued Operation 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Income From Continuing Operation Net Minority Interest 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Income Including Noncontrolling Interests 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Income Common Stockholders 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Income 5.5M 5.9M 2.6M 3.3M 283,000 --
EBITDA 6.8M 6.8M 4.3M 1.8M 3.8M --
Normalized EBITDA 7.2M 5.0M 4.4M 4.5M 5.0M --
Reconciled Depreciation 1.8M 1.8M 1.8M 1.5M 1.9M --
Basic EPS 0.22 0.23 0.10 0.13 0.01 --
Diluted EPS 0.21 0.22 0.10 0.13 0.01 --
Basic Average Shares 25.4M 25.9M 25.6M 25.7M 25.2M --
Diluted Average Shares 25.9M 26.5M 26.2M 25.7M 25.7M --
Total Unusual Items -475,000 1.8M -117,000 -2.6M -1.3M --
Total Unusual Items Excluding Goodwill -475,000 1.8M -117,000 -2.6M -1.3M --
Tax Rate For Calcs 0.15 0.08 0.15 0.15 0.13 --
Normalized Income 5.9M 4.3M 2.7M 5.6M 1.4M --
Depreciation Amortization Depletion Income Statement 1.8M 1.8M 1.8M 1.5M 1.9M --
Diluted NI Availto Com Stockholders 5.5M 5.9M 2.6M 3.3M 283,000 --
Gain On Sale Of Ppe 130,000 -- -- -- 0.00 --
Insurance And Claims 69,000 81,000 85,000 98,000 49,000 --
Net Income Continuous Operations 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Non Operating Interest Income Expense -241,000 -345,000 -470,000 -544,000 -292,000 --
Other Gand A 1.1M 1.9M 1.9M 1.7M 1.8M --
Reconciled Cost Of Revenue 2.3M 2.5M 2.9M 5.1M 2.0M --
Salaries And Wages 2.0M 2.1M 2.2M 2.3M 2.0M --
Selling And Marketing Expense 571,000 -- 651,000 707,000 749,000 109,000
Total Expenses 7.9M 8.4M 9.5M 11.5M 8.5M --
Total Other Finance Cost 241,000 345,000 470,000 -- 292,000 -611,000
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 8.4M 11.3M 22.0M 17.8M 9.5M --
Cash Cash Equivalents And Short Term Investments 8.4M 11.3M 22.0M 17.8M 9.5M --
Accounts Receivable 10.1M 11.9M 11.8M 13.9M 13.2M --
Receivables 10.1M 11.9M 11.8M 13.9M 13.2M --
Inventory 6.7M 5.6M 5.5M 5.8M 5.3M --
Other Current Assets 1.4M 1.8M 837,000 995,000 1.0M --
Current Assets 26.7M 30.5M 40.1M 38.5M 29.1M --
Gross PPE -- -- -- 1.2M -- --
Accumulated Depreciation -- -- -- -560,000 -- --
Net PPE 453,000 522,000 602,000 680,000 853,000 --
Goodwill 17.4M 17.4M 17.4M 17.4M 15.7M --
Goodwill And Other Intangible Assets 91.1M 92.7M 94.5M 96.2M 101.7M --
Other Intangible Assets 73.6M 75.3M 77.0M 78.8M 86.0M --
Total Non Current Assets 120.8M 121.8M 122.9M 124.0M 124.8M --
Total Assets 147.5M 152.4M 163.1M 162.5M 153.9M --
Current Debt And Capital Lease Obligation 255,000 262,000 267,000 283,000 263,000 --
Accounts Payable 4.1M 4.8M 5.3M 5.9M 5.5M --
Payables 4.1M 4.9M 5.4M 5.9M 5.5M --
Payables And Accrued Expenses 4.1M 4.9M 5.7M 6.3M 5.9M --
Current Accrued Expenses 2,000 82,000 330,000 358,000 401,000 --
Current Deferred Revenue 16.0M 12.6M 11.6M 13.3M 8.4M --
Current Liabilities 20.4M 17.8M 17.6M 19.9M 14.5M --
Long Term Debt 13.0M 25.0M 40.0M 40.0M 40.0M --
Long Term Debt And Capital Lease Obligation 13.1M 25.2M 40.2M 40.3M 40.5M --
Long Term Capital Lease Obligation 138,000 193,000 245,000 295,000 489,000 --
Total Non Current Liabilities Net Minority Interest 13.1M 25.2M 40.2M 40.3M 40.5M --
Total Liabilities Net Minority Interest 33.6M 43.0M 57.8M 60.2M 55.0M --
Common Stock 27.8M 27.6M 27.8M 27.7M 27.9M --
Capital Stock 27.8M 27.6M 27.8M 27.7M 27.9M --
Additional Paid In Capital 7.3M 7.1M 6.7M 6.5M 6.2M --
Retained Earnings 88.3M 84.2M 80.3M 77.7M 74.3M --
Gains Losses Not Affecting Retained Earnings -9.5M -9.5M -9.5M -9.5M -9.5M --
Other Equity Adjustments -9.5M -9.5M -9.5M -9.5M -9.5M --
Common Stock Equity 113.9M 109.4M 105.2M 102.3M 98.9M --
Stockholders Equity 113.9M 109.4M 105.2M 102.3M 98.9M --
Total Equity Gross Minority Interest 113.9M 109.4M 105.2M 102.3M 98.9M --
Total Capitalization 126.9M 134.4M 145.2M 142.3M 138.9M --
Net Tangible Assets 22.8M 16.7M 10.8M 6.1M -2.8M --
Tangible Book Value 22.8M 16.7M 10.8M 6.1M -2.8M --
Working Capital 6.2M 12.8M 22.6M 18.6M 14.6M --
Invested Capital 126.9M 134.4M 145.2M 142.3M 138.9M --
Total Debt 13.4M 25.5M 40.5M 40.6M 40.8M --
Net Debt 4.6M 13.7M 18.0M 22.2M 30.5M --
Share Issued 25.4M 25.4M 25.6M 25.6M 25.6M --
Ordinary Shares Number 25.4M 25.4M 25.6M 25.6M 25.6M --
Buildings And Improvements -- -- -- 537,000 -- --
Capital Lease Obligations 393,000 455,000 512,000 578,000 752,000 --
Current Capital Lease Obligation 255,000 262,000 267,000 283,000 263,000 --
Current Deferred Liabilities 16.0M 12.6M 11.6M 13.3M 8.4M --
Finished Goods 4.8M 4.5M 4.9M 5.6M 4.6M --
Income Tax Payable 9,000 9,000 54,000 54,000 -- --
Interest Payable 2,000 82,000 330,000 358,000 401,000 --
Inventories Adjustments Allowances -190,000 -172,000 -169,000 -176,000 -257,000 --
Leases -- -- -- 99,000 -- --
Machinery Furniture Equipment -- -- -- 604,000 -- --
Non Current Deferred Assets 29.3M 28.6M 27.9M 27.1M 22.3M --
Non Current Deferred Taxes Assets 29.0M 28.3M 27.5M 26.8M 21.9M --
Properties -- -- -- 0.00 -- --
Raw Materials 2.1M 1.2M 829,000 369,000 880,000 --
Total Tax Payable 9,000 9,000 54,000 54,000 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 10.8M 6.0M 4.2M 8.9M 2.0M --
Cash Flow From Continuing Operating Activities 10.8M 6.0M 4.2M 8.9M 2.0M --
Depreciation And Amortization 1.8M 1.8M 1.8M 1.5M 1.9M --
Depreciation Amortization Depletion 1.8M 1.8M 1.8M 1.5M 1.9M --
Stock Based Compensation 533,000 436,000 244,000 374,000 291,000 --
Deferred Tax -1.2M 512,000 -737,000 -6.3M 43,000 --
Deferred Income Tax -1.2M 512,000 -737,000 -6.3M 43,000 --
Change In Working Capital 3.7M -914,000 230,000 8.1M -248,000 --
Changes In Account Receivables 1.7M -95,000 2.1M -645,000 -9.4M --
Change In Receivables 1.7M -95,000 2.1M -645,000 -9.4M --
Change In Inventory -1.1M -41,000 257,000 3.3M 230,000 --
Change In Payables And Accrued Expense -798,000 -746,000 -602,000 420,000 1.6M --
Change In Payable -718,000 -498,000 -574,000 463,000 1.2M --
Change In Other Working Capital 3.5M 897,000 -1.7M 5.0M 7.8M --
Other Non Cash Items 36,000 45,000 48,000 50,000 33,000 --
Capital Expenditure -81,000 -- -2,000 -7,000 -20,000 -11,000
Purchase Of PPE -1,000 0.00 -2,000 -7,000 -20,000 --
Net PPE Purchase And Sale 129,000 0.00 -2,000 -7,000 -20,000 --
Investing Cash Flow 49,000 0.00 -2,000 -7,000 -80.0M --
Cash Flow From Continuing Investing Activities 49,000 0.00 -2,000 -7,000 -80.0M --
Issuance Of Debt -- -- -- 0.00 -- --
Repayment Of Debt -12.1M -15.1M -76,000 -- -84,000 -29,000
Net Issuance Payments Of Debt -12.1M -15.1M -76,000 -70,000 39.9M --
Repurchase Of Capital Stock -1.6M -2.1M 0.00 0.00 0.00 --
Net Common Stock Issuance -1.6M -2.1M 0.00 0.00 0.00 --
Common Stock Payments -1.6M -2.1M 0.00 0.00 0.00 --
Financing Cash Flow -13.6M -17.2M -45,000 -104,000 39.5M --
Cash Flow From Continuing Financing Activities -13.6M -17.2M -45,000 -104,000 39.5M --
Effect Of Exchange Rate Changes -122,000 530,000 -10,000 -461,000 52,000 --
Changes In Cash -2.8M -11.2M 4.2M 8.8M -38.5M --
Beginning Cash Position 11.3M 22.0M 17.8M 9.5M 48.0M --
End Cash Position 8.4M 11.3M 22.0M 17.8M 9.5M --
Free Cash Flow 10.7M 6.0M 4.2M 8.9M 2.0M --
Change In Account Payable -718,000 -453,000 -574,000 409,000 1.2M --
Change In Accrued Expense -80,000 -248,000 -28,000 -43,000 401,000 --
Change In Income Tax Payable 0.00 -- -- 54,000 0.00 0.00
Change In Interest Payable -80,000 -248,000 -28,000 -43,000 401,000 --
Change In Prepaid Assets 364,000 -929,000 158,000 52,000 -477,000 --
Change In Tax Payable 0.00 -- -- 54,000 0.00 0.00
Long Term Debt Issuance -- -- -- 0.00 -- --
Long Term Debt Payments -12.1M -15.1M -76,000 -- -84,000 -29,000
Net Foreign Currency Exchange Gain Loss 605,000 -1.8M -11,000 1.8M -325,000 --
Net Income From Continuing Operations 5.5M 5.9M 2.6M 3.3M 283,000 --
Net Long Term Debt Issuance -12.1M -15.1M -76,000 -70,000 39.9M --
Net Other Financing Charges -- -- -- -49,000 -- --
Net Other Investing Changes -- -- -- 0.00 -- --
Operating Gains Losses 475,000 -1.8M -11,000 1.8M -325,000 --
Proceeds From Stock Option Exercised 45,000 10,000 31,000 15,000 10,000 --
NEWS
Loading news...
TRENDING
Loading...